MedPage Today, August 1, 2024: When the company that makes Wegovy weight loss drugs say it reduces major cardiovascular events by 20% they really mean it reduces that risk by 1.5% for each patient. That’s because only 8% of the placebo group had major cardiovascular events, compared to 6.5% of the Wegovy patients. Isn’t that misleading? We explain why most weight loss patients will not benefit in terms of heart disease, because the benefit is small and requires staying on Wegovy for almost 3 years.
Read More »Author: Caroline Bradford
ADHD Treatment: Medications and Alternatives
ADHD is a frequently diagnosed condition, and many children and adults take medication to help control the symptoms. But the medication can have serious side effects, there are concerns that ADHD is overdiagnosed and the medications are misused or abused, and there are alternative treatments. This article explains the risk and benefits of medications and includes alternatives that can reduce dosage or replace medications.
Read More »NCHR and Consumer Groups Applaud Decision to Hold Amazon Responsible for Certain Hazardous Products
July 30, 2024: NCHR and other consumer groups’ joint press release expresses their support for the CPSC decision to hold Amazon responsible for certain hazardous products sold by third parties on their website. According to the Decision and Order, Amazon is a “distributor” of certain defective or non-compliant products and is therefore responsible for the illegal sale of those products. Amazon must submit plans to notify consumers about specific hazardous products and offer incentives to return or destroy the products.
Read More »Open Letter to the FDA: You’re Protecting the Wrong People
MedShadow, July 23, 2024: We agree with Medshadow that it is outrageous that the FDA is warning companies about fraudulent tests that mean their medications may not be safe or effective but are not warning patients who are buying these medications.
Read More »NCHR Letter for the Record for Hearing on the Consumer Product Safety Commission Budget
July 22, 2024: NCHR’s letter for the record for the House hearing: “The Fiscal Year 2025 Consumer Product Safety Commission Budget” describes the accomplishments of the CPSC and urges Congress to support CPSC’s life-saving work evaluating consumer products, especially those for children, in order to keep all of us safe.
Read More »